PULM
Pulmatrix Inc
NASDAQ: PULM · HEALTHCARE · BIOTECHNOLOGY
$1.26
+1.61% today
Updated 2026-04-30
Market cap
$4.67M
P/E ratio
—
P/S ratio
2,459.21x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$1 – $9
Volume
0.1M
Pulmatrix Inc (PULM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+53.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-17.4%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-35.8%
2026-03-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.25 | — | $2.12 | $1.36 | -35.8% |
| 2025-10-16 | $-0.24 | — | $4.76 | $4.81 | +1.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $-0.25 | — | — | — |
| 2025-09-30 | $0.00 | $-0.24 | — | — | — |
| 2025-06-30 | $0.00 | $-0.42 | — | — | — |
| 2025-03-31 | — | $-0.50 | — | — | — |
| 2024-12-31 | — | $-0.54 | — | $3000.00 | -99.9% |
| 2024-09-30 | — | $-0.71 | — | $366000.00 | -79.1% |
| 2024-06-30 | — | $-1.59 | — | $1.55M | -15.8% |
| 2024-03-31 | $0.23 | $0.23 | -1.8% | $5.88M | +292.6% |
| 2023-12-31 | $-1.04 | $-0.57 | +45.2% | $2.20M | — |
| 2023-09-30 | $-1.05 | $-1.03 | +1.9% | $1.75M | — |
| 2023-06-30 | $-1.23 | $-1.04 | +15.4% | $1.84M | — |
| 2023-03-31 | $-1.22 | $-1.22 | +0.0% | $1.50M | — |
Frequently asked questions
Has Pulmatrix Inc beaten earnings estimates?
Pulmatrix Inc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does PULM stock react to earnings?
PULM stock has moved an average of -17.4% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.